Professor, Ophthalmology and Epidemiology, Perelman School of Medicine

Ophthalmology

John Kempen, MD is an expert in the field of Ophthalmology. He went to medical school at University of California San Diego School of Medicine. University of California San Diego School of Medicine is ranked 17 in research and 19 in primary care medicine He received awards:"CMS Meaningful Use Stage 1 Certification" and "Fellow (FAAO)". Dr. John Kempen is also a published doctor. He has 100 publication published. The most recent publication is: Effect of visual impairment on neuropsychological test performance. John Kempen accepts all Medicare patients.

Publications

---

• Risk of Retinal Neovascularization in Cases of Uveitis.
• Acute onset Anterior uveitis after darbepoetin alfa infusion.
• Outcome of Treatment of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial 2-Year Results.
• Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial.
• The Risk of IntraOcular Pressure Elevation in Pediatric Noninfectious Uveitis.
• Immunosuppressive therapy and cancer risk in Ocular inflammation patients: fresh evidence and more questions.
• Risk of Cataract among Subjects with Acquired Immune Deficiency Syndrome Free of Ocular Opportunistic Infections.
• Immune Markers Predictive of Neuropsychiatric Symptoms in HIV Infected Youth.
• Ocular Toxicity in BRAF Mutant Cutaneous Melanoma Patients Treated With Vemurafenib.
• PeriOcular Corticosteroid Injections in Uveitis: Effects and Complications.
• Outcomes of Cataract Surgery in Patients With Uveitis: a Systematic Review and Meta-Analysis.
• Cost-Effectiveness of Fluocinolone Acetonide Implant versus Systemic Therapy for Noninfectious Intermediate, Posterior, and PanUveitis.
• Risk of Retinal tear or detachment with oral fluoroquinolone use: a cohort study.
• Interobserver Agreement in Clinical Grading of Vitreous Haze Using Alternative Grading Scales.
• Difluprednate 0.05% Versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: A Phase III, Multicenter, Randomized Study.
• Factors Predictive of Remission of New-Onset Anterior Uveitis.
• Incidence of Visual Improvement in Uveitis Cases with Visual Impairment Caused by Macular Edema.
• Response of Pediatric Uveitis to Tumor Necrosis Factor-α Inhibitors.
• Risk of Choroidal Neovascularization among the Uveitides.
• Fluorescein Angiography versus Optical Coherence Tomography for Diagnosis of Uveitic Macular Edema.
• Risk of Elevated Intraocular Pressure and Glaucoma in Patients with Uveitis: Results of the Multicenter Uveitis Steroid Treatment Trial.
• Peripapillary choroidal neovascularization in Pars planitis.
• Risk factors for loss of visual acuity among patients with Uveitis associated with juvenile idiopathic arthritis: the Systemic Immunosuppressive Therapy for Eye Diseas...
• Risk of Cataract in persons with cytomegalovirus retinitis and the acquired immune deficiency syndrome.
• Risk of hypotony in noninfectious Uveitis.
• Effect of Visual impairment on neuropsychological test performance.
• Drug-induced maculopathy.
• Immune recovery Uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy.
• Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome.
• Synthesis of the literature on the effectiveness of regional anesthesia for Cataract surgery.
• The methodologic quality of clinical trials on regional anesthesia for Cataract surgery.
• Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
• Incremental cost effectiveness of prophylaxis for cytomegalovirus Disease in patients with AIDS.
• HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial.
• Methodologic rigor of clinical trials on surgical management of eyes with coexisting Cataract and glaucoma.
• Surgical strategies for coexisting glaucoma and Cataract: an evidence-based update.
• Effect of technique on intraocular pressure after combined Cataract and glaucoma surgery: An evidence-based review.
• Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis.
• Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection.
• Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy.
• Incidence of cytomegalovirus (CMV) retinitis in second Eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
• Birdshot retinochoroidopathy: Ocular complications and visual impairment.
• Mycophenolate mofetil therapy for inflammatory eye Disease.
• Retinal vascular occlusion in patients infected with human immunodeficiency virus.
• Vogt-Koyanagi-Harada Disease: clinical outcomes.
• The impact of anemia on energy and physical functioning in individuals with AIDS.
• Risk of immune recovery Uveitis in patients with AIDS and cytomegalovirus retinitis.
• Incidence of Ocular morbidity among multibacillary leprosy patients during a 2 year course of multidrug therapy.
• Incidence of Ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy.
• Incidence of and risk factors for Visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
• Causes of Visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
• Recurrent nodular Scleritis preceding an adult TINU syndrome.
• Effect of cytomegalovirus retinitis on the risk of Visual acuity loss among patients with AIDS.
• Longitudinal study of the Ocular complications of AIDS: 2. Ocular examination results at enrollment.
• Longitudinal study of the Ocular complications of AIDS: 1. Ocular diagnoses at enrollment.
• Economic impact of Visual impairment and blindness in the United States.
• Methods for identifying long-term adverse effects of treatment in patients with eye Diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study.
• Long-term risk of malignancy among patients treated with immunosuppressive agents for Ocular inflammation: a critical assessment of the evidence.
• Interobserver agreement in grading activity and site of inflammation in Eyes of patients with uveitis.
• Ocular inflammation in Behçet Disease: incidence of ocular complications and of loss of visual acuity.
• Medical management of human immunodeficiency virus infection.
• Uveitis in patients with autoimmune hepatitis.
• Ocular immune reconstitution inflammatory syndromes.
• Azathioprine for ocular inflammatory Diseases.
• Overall and cancer related mortality among patients with Ocular inflammation treated with immunosuppressive drugs: retrospective cohort study.
• Methotrexate for ocular inflammatory Diseases.
• Disparities in access to medical care for individuals with vision impairment.
• Cyclophosphamide for ocular inflammatory Diseases.
• Hypopyon in patients with Uveitis.
• Cyclosporine for ocular inflammatory Diseases.
• Mycophenolate mofetil for Ocular inflammation.
• The multicenter Uveitis steroid treatment trial: rationale, design, and baseline characteristics.
• Proof of concept for combined insertion of fluocinolone acetonide and glaucoma drainage implants for Eyes with uveitis and glaucoma.
• Adverse effects of smoking on patients with Ocular inflammation.
• Population-based prevalence of Uveitis in Southern India.
• Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency Syndrome.
• The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy.
• Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency Syndrome.
• Incidence and management of Cataract after retinal detachment repair with silicone oil in immune compromised patients with cytomegalovirus retinitis.
• Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression.
• The prevalence of refractive errors among adults in the United States, Western Europe, and Australia.
• The prevalence of Diabetic retinopathy among adult type 1 Diabetic persons in the United States.
• The prevalence of Diabetic retinopathy among adults in the United States.
• Appropriate use and reporting of uncontrolled case series in the medical literature.
• Diagnosis and treatment of microsporidial keratoconjunctivitis: literature review and case series.
• The need for a revised approach to epidemiological monitoring of the prevalence of Visual impairment.
• Risk of relapse in primary acute Anterior uveitis.
• Morphologic assessment for Glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial.
• Randomized comparison of systemic anti-inflammatory therapy versus fluocinolone acetonide implant for intermediate, posterior, and panUveitis: the multicenter Uveitis ...
• Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial--lessons for comparative effectiveness trials.
• Prevalence of age-related Macular degeneration in the United States.
• Prevalence of open-angle Glaucoma among adults in the United States.
• Causes and prevalence of Visual impairment among adults in the United States.
• Prevalence of Cataract and pseudophakia/aphakia among adults in the United States.
• Central Corneal thickness and related factors in an elderly American Chinese population.
• Early Retinal vascular abnormalities in African-American cocaine users.
• Cataract after glaucoma filtration surgery.
• Surgical treatment of coexisting Cataract and glaucoma.
• Anesthesia management during Cataract surgery.

Schools

---

• University Of California San Diego School Of Medicine

• Santa Clara Vly Med Center

• University of Washington

• Wilmer Oph Institute

Conditions Treated

---

• Anterior Scleritis
• Behçet's Disease
• Cataract
• Chorioretinitis
• View All

Doctors Specialties

---

• Ophthalmology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification
• Fellow (FAAO)

Education

---

• Johns Hopkins University
• University of Washington
• Santa Clara Valley Medical Center
• University of California San Diego School of Medicine

Hospital

---

• Hospital of the University of Pennsylvania
• Penn Presbyterian Medical Center

Drug Facts

---

NPI NUMBER		1679684385
NPPES Provider LastName		KEMPEN
NPPES Provider FirstName		JOHN
NPPES Provider ZIPCode		191042640
NPPES Provider State		PA
Specialty Description		Ophthalmology
Total Claim Count		343.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1679684385
Last Name Of The Provider	KEMPEN
First Name Of The Provider	JOHN
View All

Similar Doctors

---

	Dr. Nikisha A. Kothari, MD
	Dr. Alex B. Theventhiran, MD This Doctor is OpenDoctor Recommended.
	Dr. Brian C. Doyle, MD This Doctor is OpenDoctor Recommended.
	Dr. Ankoor R. Shah, MD This Doctor is OpenDoctor Recommended.
	Dr. Alessandra K. Intili, MD This Doctor is OpenDoctor Recommended.
	Dr. Stephen M. Soll, MD This Doctor is OpenDoctor Recommended.
	Dr. Joshua J. Ney, MD This Doctor is OpenDoctor Recommended.
	Dr. Melissa M. Wong, MD This Doctor is OpenDoctor Recommended.
	Dr. Samuel Jacobson, MD This Doctor is OpenDoctor Recommended.
	Dr. Vincent B. Lam, MD This Doctor is OpenDoctor Recommended.
	Dr. William T. Kellogg, MD
	Dr. Mustapha Shayegan, MD This Doctor is OpenDoctor Recommended.
	Dr. Allen C. Richmond, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog